Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Post-finasteride syndrome's existence is uncertain; more research needed.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Father's finasteride use may affect son's fertility and testicular function.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Finasteride's link to depression is questionable due to study flaws and potential bias.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.